American Association for Cancer Research (AACR) Publisher

publisher of

• Abstract 5276: Immunomodulatory activity of intermittent low-dose erlotinib plus sulindac: Implications for hereditary and sporadic colorectal cancer.  Cancer Research.  84:5276-5276. 2024
• Abstract B171: BX-795 enhances the efficacy of crizotinib in colorectal cancer cells by altering the activity of aurora kinases 2023
• Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer..  MOLECULAR CANCER THERAPEUTICS.  22:962-975. 2023
• Microbiota Influences on Hematopoiesis and Blood Cancers: New Horizons? 2023
• Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis.  Cancer Research Communications.  3:874-883. 2023
• Abstract 1231: A stochastic data-driven model predicts the timing and distribution of the epithelial-mesenchymal transition.  Cancer Research.  83:1231-1231. 2023
• Abstract 2847: Concurrent inactivation of PI3K and PLK1 is synergistic and overcomes acquired resistance to PI3K inhibitors in NOTCH1 MUT HNSCC.  Cancer Research.  83:2847-2847. 2023
• Abstract 3443: Aryl hydrocarbon receptor and its ligands influence the formation of colonic tertiary lymphoid tissues.  Cancer Research.  83:3443-3443. 2023
• Abstract 453: Targeting FOXL2C402G vulnerabilities in adult type ovarian granulosa cell tumors.  Cancer Research.  83:453-453. 2023
• Abstract 4994: Crizotinib enhances the efficacy of BX-795 identified by high-throughput screening of pan-active drugs in colorectal cancer cells.  Cancer Research.  83:4994-4994. 2023
• Epigenetic-Metabolic Interplay in the DNA Damage Response and Therapeutic Resistance of Breast Cancer..  Cancer Research.  83:657-666. 2023
• Abstract P6-07-01: Costs of breast cancer recurrence after initial treatment for high risk early breast cancer using SEER-Medicare linked data.  Cancer Research.  83:p6-07-01-p6-07-01. 2023
• Abstract P6-10-19: Screening of GPCR-targeting drugs for repositioning in breast cancer.  Cancer Research.  83:p6-10-19-p6-10-19. 2023
• Abstract P014: A novel role of mutant APC and n3-PUFA in reshaping cholesterol-dependent Wnt pathway-associated proteolipid nanocluster organization and signaling in colorectal cancer.  Cancer Prevention Research.  16:p014-p014. 2023
• Abstract P016: Endomembranes accumulate unesterified cholesterol in Apc mutant models and humans with CRC as assessed by RNAseq and confocal microscopy.  Cancer Prevention Research.  16:p016-p016. 2023
• Abstract A013: Metabolomics of acute vs. chronic spinach intake in an Apc-mutant genetic background: linoleate and butanoate metabolites targeting HDAC activity and IFN- signaling.  Cancer Prevention Research.  15:a013-a013. 2022
• Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers..  CLINICAL CANCER RESEARCH.  28:4479-4493. 2022
• Financial Toxicities Persist for Cancer Survivors Irrespective of Current Cancer Status: An Analysis of Medical Expenditure Panel Survey. 2022
• Abstract 236: Nuclear receptor 4A1 ligands target T-cell exhaustion in colorectal cancer.  Cancer Research.  82:236-236. 2022
• Abstract 5631: Immunomodulatory activity of sulindac plus erlotinib for colon cancer prevention in familial adenomatous polyposis.  Cancer Research.  82:5631-5631. 2022
• Abstract 5632: Combinatorial epigenetic targeting of PRC2 complexes upregulates MHC antigen presentation components in melanoma and gastrointestinal cancer cells.  Cancer Research.  82:5632-5632. 2022
• Abstract 5712: Dietary polyphenols as BRD7 and 9 inhibitors for cancer interception.  Cancer Research.  82:5712-5712. 2022
• Abstract 5713: Alternative splicing of the chromatin modifier gene BAZ1A in colorectal cancer.  Cancer Research.  82:5713-5713. 2022
• Abstract 5815: Metabolomics in an Apc-mutant genetic background: Mechanistic insights from acute vs. chronic spinach intake.  Cancer Research.  82:5815-5815. 2022
• Abstract 1858: Rb deficient HPV+ HNSCC experienced enhanced sensitivity to aurora kinase inhibitors by altering the balance of MAD2 and TRIP13 levels.  Cancer Research.  82:1858-1858. 2022
• Abstract 410: Development of novel, non-toxic rifamycins that reverse drug resistance.  Cancer Research.  82:410-410. 2022
• Abstract 819: ERBB4 mediates IL10-induced growth of EGFR-independent colon tumors.  Cancer Research.  82:819-819. 2022
• Abstract GS1-09: Inhibition of GPX4 induces preferential death of p53-mutant triple-negative breast cancer cells.  Cancer Research.  82:gs1-09-gs1-09. 2022
• Single-cell RNA Sequencing Reveals How the Aryl Hydrocarbon Receptor Shapes Cellular Differentiation Potency in the Mouse Colon..  Cancer Prevention Research.  15:17-28. 2022
• Systematic Profiling of DNMT3A Variants Reveals Protein Instability Mediated by the DCAF8 E3 Ubiquitin Ligase Adaptor..  Cancer Discovery.  12:220-235. 2022
• Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models..  MOLECULAR CANCER THERAPEUTICS.  20:2352-2361. 2021
• Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma..  Cancer Research Communications.  1:65-78. 2021
• Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma..  CLINICAL CANCER RESEARCH.  27:5528-5535. 2021
• Cigarette Smoking and Estrogen-Related Cancer-Reply..  Cancer Epidemiology, Biomarkers and Prevention.  30:1978-1978. 2021
• Cigarette Smoking and Estrogen-Related Cancer..  Cancer Epidemiology, Biomarkers and Prevention.  30:1462-1471. 2021
• Abstract 1149: Nuclear receptor 4A1 (NR4A1) antagonists target PD-L1 in colon cancer 2021
• Abstract 1553: Intratumoral delivery of STING agonist results in radiographic response in spontaneous canine high-grade glioma.  Cancer Research.  81:1553-1553. 2021
• Abstract 2106: Combined deacetylase and bromodomain inhibition downregulates ERCC2 and suppresses growth of metastatic colon cancer cells.  Cancer Research.  81:2106-2106. 2021
• Abstract 2428: NR4A1 ligands inhibits PSPC1 regulated EMT and stemness markers in breast, lung and liver cancer cells 2021
• Abstract 368: Aurora kinase inhibitors cause cell death in HPV+ cells: A plausible treatment option for HPV+ cancers.  Cancer Research.  81:368-368. 2021
• Abstract 369: Identification of pathways that enhance cell death in NOTCH1-mutant HNSCC.  Cancer Research.  81:369-369. 2021
• Abstract 629: Flavonoids are NR4A1 antagonists and target PAX3-FOXO1 and G9a in alveolar rhabdomyosarcoma cells 2021
• Loss of Aryl Hydrocarbon Receptor Promotes Colon Tumorigenesis in ApcS580/+; KrasG12D/+ Mice..  Molecular Cancer Research.  19:771-783. 2021
• Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP)..  Cancer Prevention Research.  14:325-336. 2021
• The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells. 2021
• The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer..  Molecular Cancer Research.  19:180-191. 2021
• Transient Activation of the Hedgehog-Gli Pathway Rescues Radiotherapy-Induced Dry Mouth via Recovering Salivary Gland Resident Macrophages..  Cancer Research.  80:5531-5542. 2020
• The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them..  Cancer Epidemiology, Biomarkers and Prevention.  29:1887-1903. 2020
• Abstract 1: Sulindac plus phospholipid is effective for polyp reduction and safer than sulindac alone.  Cancer Research.  80:1-1. 2020
• Nucleostemin Modulates Outcomes of Hepatocellular Carcinoma via a Tumor Adaptive Mechanism to Genomic Stress..  Molecular Cancer Research.  18:723-734. 2020
• Abstract B59: Co-evolution between tumor cells and immune system in the setting of T-cell immunotherapy.  CANCER IMMUNOLOGY RESEARCH.  8:b59-b59. 2020
• A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity..  Cancer Research.  80:1011-1023. 2020
• Abstract A104: A stochastic model of tumor-immune evasion predicts sustained coevolution and tumor antigen downregulation 2020
• Sustained Coevolution in a Stochastic Model of Cancer-Immune Interaction. 2020
• Differential Contributions of Pre- and Post-EMT Tumor Cells in Breast Cancer Metastasis..  Cancer Research.  80:163-169. 2020
• Abstract 1662: In vivo drug response evaluation in anaplastic thyroid cancer patient-derived tumor xenografts following high-throughput screening.  Cancer Research.  80:1662-1662. 2020
• Abstract A10: Fusobacteria upregulates PD-L1 in head and neck cancer cell lines: Potential mechanism for immune evasion.  Cancer Research.  80:a10-a10. 2020
• Abstract B20: Unbiased high-throughput screenings to identify combination therapies targeting RAS-mutated colorectal cancer.  Molecular Cancer Research.  18:b20-b20. 2020
• Abstract B41: Bis-indole derived NR4A1 antagonist induces PD-L1 degradation and enhances antitumor immunity.  CANCER IMMUNOLOGY RESEARCH.  8:b41-b41. 2020
• Abstract P3-03-08: Identification of drugs that induce the death or suppress the growth of p53-mutant breast cancer.  Cancer Research.  80:p3-03-08-p3-03-08. 2020
• Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma..  Molecular Cancer Research.  17:2221-2232. 2019
• A Mutation in Histone H2B Represents a New Class of Oncogenic Driver..  Cancer Discovery.  9:1438-1451. 2019
• Abstract 1195: Stochastic co-evolution of the adaptive immune system and an evading cancer population.  Cancer Research.  79:1195-1195. 2019
• Abstract 2783: OMICS analysis of breast cancer PDX tumors to determine CTC-cluster-specific signature in predicting breast cancer metastasis.  Cancer Research.  79:2783-2783. 2019
• CCAR2 acetylation establishes a BET/BRD9 acetyl switch in response to combined deacetylase and bromodomain inhibition.  Cancer Research.  79:2614-2614. 2019
• Overcoming therapy resistance in stem cell-rich triple negative breast cancer through p38 MAP kinase inhibition.  Cancer Research.  79:4669-4669. 2019
• E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms. 2019
• Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer..  Cancer Research.  79:1831-1843. 2019
• Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition..  Cancer Research.  79:918-927. 2019
• Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors..  Molecular Cancer Research.  17:794-805. 2019
• Abstract 2824: Modulation of oral cancer cells survival and invasiveness by fusobacteria.  Cancer Research.  79:2824-2824. 2019
• Abstract LB-320: PPTC testing of an OLIG2 inhibitor CT-179 in patient-derived orthotopic xenograft mouse models of pediatric GBM.  Cancer Research.  79:lb-320-lb-320. 2019
• Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma..  MOLECULAR CANCER THERAPEUTICS.  17:2756-2766. 2018
• TGF-Induced Lung Cancer Cell Migration Is NR4A1-Dependent..  Molecular Cancer Research.  16:1991-2002. 2018
• CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols..  CLINICAL CANCER RESEARCH.  24:4976-4987. 2018
• Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer..  Cancer Research.  78:4459-4470. 2018
• Long-Chain n-3 Fatty Acids Attenuate Oncogenic KRas-Driven Proliferation by Altering Plasma Membrane Nanoscale Proteolipid Composition..  Cancer Research.  78:3899-3912. 2018
• Abstract B41: Transcriptome-wide profiling identifies novel differential genes associated with health disparity of prostate cancer.  Cancer Epidemiology, Biomarkers and Prevention.  27:b41-b41. 2018
• Immuno-modulation of macrophages by ovarian cancer stem cells in an in vitro 3D spheroid platform.  Cancer Research.  78:118-118. 2018
• Specificity Protein Transcription Factors and Cancer: Opportunities for Drug Development. 2018
• SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma. 2018
• Abstract 2945: Arsenic trioxide sensitizes glioma stem cells to brain penetrant PI3K and mTOR inhibitor GDC-0084.  Cancer Research.  78:2945-2945. 2018
• Abstract 4819: High-throughput screening of glioma stem-like cells (GSCs) identifies synergistic therapeutic combination of FGFR inhibitor and CDK4/6 inhibitor.  Cancer Research.  78:4819-4819. 2018
• Abstract 5139: F. nucleatum induces invasive phenotypes in oral cancer cells in vitro.  Cancer Research.  78:5139-5139. 2018
• Abstract LB-041: Establishment and characterization of patient derived orthotopic xenograft mouse models representing a serial of primary and recurrent pediatric brain tumors.  Cancer Research.  78:lb-041-lb-041. 2018
• Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids. 2017
• Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric. 2017
• Early Exposure to a High Fat/High Sugar Diet Increases the Mammary Stem Cell Compartment and Mammary Tumor Risk in Female Mice. 2017
• HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas..  Cancer Research.  77:5313-5326. 2017
• Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors..  Cancer Prevention Research.  10:467-477. 2017
• Abstract 3298: Diindolylmethane and its halogenated analogues induce autophagy in human prostate cancer cells via induction of the astrocyte-elevated gene-1 (AEG-1) 2017
• Abstract 563: Quantitative EMT expression score for predicting survival outcome.  Cancer Research.  77:563-563. 2017
• Abstract 576: Neoadjuvant immunotherapy improves efficacy of image-guided thermal ablation to generate curative responses in a murine breast cancer model.  Cancer Research.  77:576-576. 2017
• Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient?.  CLINICAL CANCER RESEARCH.  23:3263-3268. 2017
• Prevention by tolfenamic acid and characterization of the molecular targets in Pirc and FAP colorectal adenomas.  Cancer Research.  77:2229-2229. 2017
• PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1..  Cancer Research.  77:732-741. 2017
• Abstract 1244: An in vitro biological assay to identify small molecule upregulators of let-7 miRNA in LIN28- positive ovarian cancer cells.  Cancer Research.  77:1244-1244. 2017
• Abstract 4214: Identification of personalized active agents in pediatric gliomas through high-throughput drug screening in matching pairs of patient derived orthotopic xenograft (PDOX) neurosphere and monolayer cells.  Cancer Research.  77:4214-4214. 2017
• Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors. 2017
• The Cytoskeletal Adapter Protein Spinophilin Regulates Invadopodia Dynamics and Tumor Cell Invasion in Glioblastoma. 2016
• A New Model to Study the Role of Arachidonic Acid in Colon Cancer Pathophysiology..  Cancer Prevention Research.  9:750-757. 2016
• Novel polypectomy system in a preclinical model of colon cancer.  Cancer Research.  76:839-839. 2016
• Targeted Deletion of p53 in Lgr5-Expressing Intestinal Stem Cells Promotes Colon Tumorigenesis in a Preclinical Model of Colitis-Associated Cancer..  Cancer Research.  75:5392-5397. 2015
• In vivo regulation of colonic cell proliferation, differentiation, apoptosis, and P27Kip1 by dietary fish oil and butyrate in rats..  Cancer Prevention Research.  8:1076-1083. 2015
• Abstract B33: Regulation and function of Nrf2-associated long noncoding RNA.  Cancer Prevention Research.  8:b33-b33. 2015
• Abstract CN12-02: Dietary HDAC inhibitors: Prevention or therapy?.  Cancer Prevention Research.  8:cn12-02-cn12-02. 2015
• Dietary -Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPAR..  Cancer Prevention Research.  8:807-816. 2015
• Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors..  MOLECULAR CANCER THERAPEUTICS.  14:2143-2153. 2015
• Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test..  Molecular Cancer Research.  13:993-1002. 2015
• Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma..  CLINICAL CANCER RESEARCH.  21:1741-1751. 2015
• Targeting apoptosis pathways in cancer--letter..  Cancer Prevention Research.  8:338-338. 2015
• ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas..  Cancer Research.  75:1035-1045. 2015
• A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner..  Cancer Discovery.  4:1387-1397. 2014
• The cancer prevention and control research network: An interactive systems approach to advancing cancer control implementation research and practice..  Cancer Epidemiology, Biomarkers and Prevention.  23:2512-2521. 2014
• Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. 2014
• Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival. 2014
• Validating self-reported mammography use in vulnerable communities: findings and recommendations..  Cancer Epidemiology, Biomarkers and Prevention.  23:1649-1658. 2014
• Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold. 2014
• MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expression..  MOLECULAR CANCER THERAPEUTICS.  13:1942-1951. 2014
• The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells..  Molecular Cancer Research.  12:527-538. 2014
• Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. 2014
• The NADH oxidase ENOX1, a critical mediator of endothelial cell radiosensitization, is crucial for vascular development..  Cancer Research.  74:38-43. 2014
• Transient activation of hedgehog pathway rescued irradiation-induced hyposalivation by preserving salivary stem/progenitor cells and parasympathetic innervation. 2014
• Abstract CN02-03: Fat-fiber combination: The missing ingredient?.  Cancer Prevention Research.  6:cn02-03-cn02-03. 2013
• Developing Lipid Nanoparticle-Based siRNA Therapeutics for Hepatocellular Carcinoma Using an Integrated Approach.  MOLECULAR CANCER THERAPEUTICS.  12:2308-2318. 2013
• Ring-DIMs induce mitochondrial dysfunction and ER stress in human prostate cancer cells.  MOLECULAR CANCER THERAPEUTICS.  12:b256-b256. 2013
• Targeting fibroblast growth factor pathways in prostate cancer..  CLINICAL CANCER RESEARCH.  19:5856-5866. 2013
• The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells..  MOLECULAR CANCER THERAPEUTICS.  12:2483-2493. 2013
• Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. 2013
• Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and -catenin..  Cancer Research.  73:5473-5484. 2013
• miR-150 blocks MLL-AF9-associated leukemia through oncogene repression..  Molecular Cancer Research.  11:912-922. 2013
• The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer. 2013
• FGFR1 is essential for prostate cancer progression and metastasis..  Cancer Research.  73:3716-3724. 2013
• Identification of PTHrP(12-48) as a plasma biomarker associated with breast cancer bone metastasis..  Cancer Epidemiology, Biomarkers and Prevention.  22:972-983. 2013
• FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer..  Cancer Research.  73:1981-1992. 2013
• Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms. 2013
• Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients..  CLINICAL CANCER RESEARCH.  18:6758-6770. 2012
• Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters..  MOLECULAR CANCER THERAPEUTICS.  11:1852-1862. 2012
• Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer.  MOLECULAR CANCER THERAPEUTICS.  11:1421-1431. 2012
• In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry..  Cancer Research.  72:2738-2745. 2012
• Different expression of AHCYL1 affecting ovarian carcinogenesis between chickens and women.  Cancer Research.  72:4007-4007. 2012
• Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors..  Cancer Research.  72:1485-1493. 2012
• Abstract A38: Whole methylome explorations of paired lung tumor and non-tumor clinical samples.  CLINICAL CANCER RESEARCH.  18:a38-a38. 2012
• Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells..  MOLECULAR CANCER THERAPEUTICS.  11:108-118. 2012
• Autophagy enhanced by microtubule- and mitochondrion-associated MAP1S suppresses genome instability and hepatocarcinogenesis..  Cancer Research.  71:7537-7546. 2011
• P4-05-02: Early Developmental Exposures to a High Carbohydrate/High Fat Diet Affect Glucose Metabolism and Mammary Cancer Susceptibility. 2011
• Area-level socioeconomic position and repeat mammography screening use: results from the 2005 National Health Interview Survey. 2011
• Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer..  Cancer Epidemiology, Biomarkers and Prevention.  20:2438-2449. 2011
• Dietary fish oil promotes colonic apoptosis and mitochondrial proton leak in oxidatively stressed mice. 2011
• In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance..  Cancer Research.  71:4742-4747. 2011
• Characterization of the oncogenic activity of the novel TRIM59 gene in mouse cancer models..  MOLECULAR CANCER THERAPEUTICS.  10:1229-1240. 2011
• Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: Effect of a chemoprotective diet.  Cancer Research.  71:1160-1160. 2011
• Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth..  Cancer Research.  71:2466-2475. 2011
• Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk..  Cancer Research.  71:2098-2107. 2011
• GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway..  Molecular Cancer Research.  9:195-202. 2011
• Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET..  CLINICAL CANCER RESEARCH.  17:550-559. 2011
• Abstract 1379: High throughput screening to identify molecules that alter VHL stability.  Cancer Research.  71:1379-1379. 2011
• Singleminded-2s (Sim2s) Promotes Breast Tumor Cell Differentiation and Inhibits Metastasis in MCF10DCIS.COM Cells.  Cancer Research.  70:p4-06-06-p4-06-06. 2010
• Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL. 2010
• Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer..  MOLECULAR CANCER THERAPEUTICS.  9:3003-3014. 2010
• Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth..  Cancer Research.  70:6824-6836. 2010
• Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia..  Cancer Research.  70:4949-4960. 2010
• Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells..  Molecular Cancer Research.  8:739-750. 2010
• Abstract 4075: Tolfenamic Acid Inhibits Prostate Cancer Cells Growth and Tumor Development in Orthotopic Mice 2010
• Weight Loss via exercise with controlled dietary intake may affect phospholipid profile for cancer prevention in murine skin tissues..  Cancer Prevention Research.  3:466-477. 2010
• Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer..  Cancer Prevention Research.  3:312-321. 2010
• Abstract 582: Targeting the blood-brain barrier with a non-canonical iron-mimicry mechanism: A translational approach for the detection and treatment of human brain tumors.  Cancer Research.  70:582-582. 2010
• Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers..  Cancer Prevention Research.  2:1015-1022. 2009
• Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-{alpha} and PTGS2..  CLINICAL CANCER RESEARCH.  15:6780-6789. 2009
• Identification of actively translated mRNA transcripts in a rat model of early-stage colon carcinogenesis..  Cancer Prevention Research.  2:984-994. 2009
• Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells..  Cancer Prevention Research.  2:683-693. 2009
• p21 Expression Is Induced by Activation of Nuclear Nerve Growth Factor–Induced Bα (Nur77) in Pancreatic Cancer Cells.  Molecular Cancer Research.  7:1169-1178. 2009
• Noninvasive detection of candidate molecular biomarkers in subjects with a history of insulin resistance and colorectal adenomas..  Cancer Prevention Research.  2:590-597. 2009
• The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression..  MOLECULAR CANCER THERAPEUTICS.  8:1207-1217. 2009
• Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. 2009
• Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis. 2009
• Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression..  MOLECULAR CANCER THERAPEUTICS.  8:533-542. 2009
• Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer..  CLINICAL CANCER RESEARCH.  15:543-552. 2009
• 1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth. 2008
• ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells..  MOLECULAR CANCER THERAPEUTICS.  7:3739-3750. 2008
• Abstract B84: NADPH oxidase 1 (NOX1) and related NOX isoforms as key mediators of NFB signaling in colon cancer.  Cancer Prevention Research.  1:b84-b84. 2008
• Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference..  CLINICAL CANCER RESEARCH.  14:6387-6395. 2008
• Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes..  MOLECULAR CANCER THERAPEUTICS.  7:3363-3372. 2008
• Leptin enhances cholangiocarcinoma cell growth..  Cancer Research.  68:6752-6761. 2008
• The untapped potential of genetically engineered mouse models in chemoprevention research: opportunities and challenges..  Cancer Prevention Research.  1:161-166. 2008
• 5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells..  MOLECULAR CANCER THERAPEUTICS.  7:2109-2120. 2008
• Curcumin decreases specificity protein expression in bladder cancer cells. 2008
• Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice..  Cancer Research.  68:3985-3991. 2008
• Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium. 2008
• Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage..  Cancer Research.  67:11594-11600. 2007
• 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth..  CLINICAL CANCER RESEARCH.  13:6743-6752. 2007
• Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. 2007
• The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells..  Cancer Research.  67:11001-11011. 2007
• The let-7 microRNA represses cell proliferation pathways in human cells. 2007
• Docosahexaenoic acid and butyrate synergistically induce colonocyte apoptosis by enhancing mitochondrial Ca2+ accumulation..  Cancer Research.  67:5561-5568. 2007
• Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells..  MOLECULAR CANCER THERAPEUTICS.  6:1588-1598. 2007
• Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells..  Cancer Research.  67:3286-3294. 2007
• Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors..  Cancer Research.  67:2816-2823. 2007
• Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways..  Cancer Research.  67:674-683. 2007
• Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway..  Cancer Research.  67:289-299. 2007
• Quantification of the heterogeneity in breast cancer cell lines using whole-cell impedance spectroscopy..  CLINICAL CANCER RESEARCH.  13:139-143. 2007
• Bub1 up-regulation and hyperphosphorylation promote malignant transformation in SV40 tag-induced transgenic mouse models. 2006
• Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium..  CLINICAL CANCER RESEARCH.  12:6373-6378. 2006
• Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference..  CLINICAL CANCER RESEARCH.  12:6209s-6212s. 2006
• Basic mechanisms responsible for osteolytic and osteoblastic bone metastases..  CLINICAL CANCER RESEARCH.  12:6213s-6216s. 2006
• Genomics and proteomics of bone cancer..  CLINICAL CANCER RESEARCH.  12:6217s-6221s. 2006
• 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways..  MOLECULAR CANCER THERAPEUTICS.  5:2324-2336. 2006
• 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways..  MOLECULAR CANCER THERAPEUTICS.  5:1362-1370. 2006
• Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study..  CLINICAL CANCER RESEARCH.  12:2178-2184. 2006
• Activation of human long interspersed nuclear element 1 retrotransposition by benzo(a)pyrene, an ubiquitous environmental carcinogen..  Cancer Research.  66:2616-2620. 2006
• 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha..  Cancer Research.  66:2459-2467. 2006
• Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis..  Cancer Research.  66:1481-1490. 2006
• Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells..  MOLECULAR CANCER THERAPEUTICS.  5:317-328. 2006
• In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor..  Cancer Research.  66:755-762. 2006
• Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists..  Cancer Research.  66:412-418. 2006
• High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor..  Cancer Research.  65:11478-11485. 2005
• gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway..  Cancer Research.  65:11437-11446. 2005
• Guggulsterones induce apoptosis and differentiation in acute myeloid leukemia: identification of isomer-specific antileukemic activities of the pregnadienedione structure..  MOLECULAR CANCER THERAPEUTICS.  4:1982-1992. 2005
• Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer..  CLINICAL CANCER RESEARCH.  11:8258-8264. 2005
• Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway..  Cancer Research.  65:11001-11009. 2005
• Mechanism of cell cycle regulation by FIP200 in human breast cancer cells..  Cancer Research.  65:6676-6684. 2005
• Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene..  Cancer Research.  65:6534-6542. 2005
• Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. 2005
• Tissue-specific attenuation of endogenous DNA I-compounds in rats by carcinogen azoxymethane: possible role of dietary fish oil in colon cancer prevention..  Cancer Epidemiology, Biomarkers and Prevention.  14:1230-1235. 2005
• A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia. 2005
• Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis..  Cancer Research.  65:887-897. 2005
• Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure..  Cancer Epidemiology, Biomarkers and Prevention.  14:53-60. 2005
• Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat..  Cancer Research.  64:6797-6804. 2004
• Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. 2004
• Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells..  Cancer Research.  64:6740-6749. 2004
• 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells..  Cancer Research.  64:5994-6001. 2004
• A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase..  Cancer Research.  64:5767-5774. 2004
• Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors. 2004
• Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells..  MOLECULAR CANCER THERAPEUTICS.  3:833-838. 2004
• Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alpha..  Cancer Research.  64:2889-2897. 2004
• A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes..  MOLECULAR CANCER THERAPEUTICS.  3:247-260. 2004
• Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators..  Cancer Research.  64:1050-1057. 2004
• Relative validity of a food frequency questionnaire with a meat-cooking and heterocyclic amine module..  Cancer Epidemiology, Biomarkers and Prevention.  13:293-298. 2004
• Abstract A6: The ES-2 ovarian cancer causes muscle wasting in vitro and in vivo: A novel experimental model of cancer cachexia.  CLINICAL CANCER RESEARCH.  19:a6-a6.
• Metabolic phenotype and risk of obesity-related cancers in the Women's Health Initiative..  Cancer Prevention Research. 
• Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells..  Molecular Cancer Research. 
• Proteomic analysis reveals a network of inflammatory genes in epidermis associated with skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.  Cancer Research.  71:2729-2729.
• The interaction of a high-fat diet and regular moderate intensity exercise on intestinal polyp development in Apc Min/+ mice..  Cancer Prevention Research.  2:641-649.
• Tet2 Inactivation Enhances the Antitumor Activity of Tumor-Infiltrating Lymphocytes..  Cancer Research. 1965-1976. 2021
• Determining efficacy of drug combinations identified by unbiased high throughput screening for RAS-mutated colorectal cancer.  Cancer Research. 550-550. 2020
• Dietary polyphenols as epigenetic 'reader' inhibitors.  Cancer Research. 3477-3477. 2020
• High throughput chemical profiling of chemoresistant triple negative breast cancer.  Cancer Research. 4106-4106. 2020
• Optimization of dosing regimens of sulindac in combination with erlotinib for small intestine and colorectal cancer prevention.  Cancer Research. 21-21. 2020
• Out-of-pocket expenditure, probability of underinsurance and health services utilization among non-elderly cancer survivors.  Cancer Research. 4340-4340. 2020
• An ethnographic study of African American men's prostate cancer treatment decision-making.  Cancer Epidemiology, Biomarkers and Prevention. a047-a047. 2020
• Exosomes-associated miR-5001, miR-3692 and miR-4529 are novel biomarkers for aggressive prostate cancer and associated with poor prognosis in African American patients.  Cancer Epidemiology, Biomarkers and Prevention. c029-c029. 2020
• Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays in triple negative breast cancer.  Cancer Research. pd5-01-pd5-01. 2020
• Abstract A52: Serially passaging ovarian cancer spheroids as an in situ model for emergence of chemoresistance and enrichment of cancer stem cells.  CLINICAL CANCER RESEARCH. a52-a52. 2020
• Abstract 2171: Activatable nanodelivery of high payload gemcitabine augments therapeutic efficacy in murine breast and pancreatic cancer models.  Cancer Research. 2171-2171. 2019
• Abstract 2171: Activatable nanodelivery of high payload gemcitabine augments therapeutic efficacy in murine breast and pancreatic cancer models.  2171-2171. 2019
• Abstract 2614: CCAR2 acetylation establishes a BET/BRD9 acetyl switch in response to combined deacetylase and bromodomain inhibition.  2614-2614. 2019
• Abstract 2783: OMICS analysis of breast cancer PDX tumors to determine CTC-cluster-specific signature in predicting breast cancer metastasis.  2783-2783. 2019
• Abstract 3952: Localized nanodelivery combined with immunotherapy promotes curative anti-tumor responses in a murine breast cancer model.  3952-3952. 2019
• Abstract 3952: Localized nanodelivery combined with immunotherapy promotes curative anti-tumor responses in a murine breast cancer model.  Cancer Research. 3952-3952. 2019
• Abstract 5074: Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP.  5074-5074. 2019
• Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP.  Cancer Research. 5074-5074. 2019
• Single cell transcriptomic profiling of ex vivo tumoroid models reveal therapeutic vulnerabilities of pancreatic ductal adenocarcinoma.  Cancer Research. 1402-1402. 2019
• Metastatic breast cancer alliance's patient education and access to trials: Perceptions and actions.  Cancer Research. p6-14-03-p6-14-03. 2019
• A general probabilistic algorithm to predict de novo mutations in familial diseases as demonstrated in Li-Fraumeni Syndrome.  Cancer Research. 2406-2406. 2019
• Abstract 2824: Modulation of oral cancer cells survival and invasiveness by fusobacteria.  2824-2824. 2019
• Abstract 4669: Overcoming therapy resistance in stem cell-rich triple negative breast cancer through p38 MAP kinase inhibition.  4669-4669. 2019
• Abstract LB-320: PPTC testing of an OLIG2 inhibitor CT-179 in patient-derived orthotopic xenograft mouse models of pediatric GBM.  lb-320-lb-320. 2019
• Breast cancer cells exhibit enhanced proliferation, invasion, PLAU expression and chemoresistance when exposed to fluid shear stress in an innovative 3D bioreactor.  Cancer Research. 187-187. 2018
• Circadian dysregulation via exposure to light at night alters DNA methylation of cancer-associated genes in murine mammary tissue.  Cancer Research. lb-237-lb-237. 2018
• Discovery of potent Abelson kinase inhibitors from the scaffold of pyrano[2,3-d]pyrimidin-7-one.  Cancer Research. 1661-1661. 2018
• Dysregulated microRNAs in aflatoxin-induced hepatocellular carcinoma: Serum miR-182 as a potential predictive biomarker.  Cancer Research. 5401-5401. 2018
• Genomic profiling of canine glioma: Comparative analyses with respect to drivers of human glioma.  Cancer Research. 1176-1176. 2018
• Identification of personalized active agents in pediatric medulloblastoma through high-throughput drug screening in matching pairs of patient derived orthotopic xenograft neurosphere and monolayer cells.  Cancer Research. lb-069-lb-069. 2018
• Pharmacogenomic screen identifies KMT2D mutations as a biomarker of sensitivity to Aurora kinase inhibition in head and neck and cervical squamous cell carcinoma.  Cancer Research. 4646-4646. 2018
• Streptococcus gallolyticus in colorectal cancer development.  Cancer Research. 5141-5141. 2018
• Abstract A33: Patient-specific evaluation of chemoresistance and tumor recurrence using ovarian cancer stem cell spheroids.  CLINICAL CANCER RESEARCH. a33-a33. 2018
• Abstract B023: Identification and biochemical validation of piperlongumine as a potent therapeutic against neuroendocrine prostate cancer.  Cancer Research. b023-b023. 2018
• A miRNA signature linked to human environmental risk defined from carcinogen-induced and genetically-driven colon carcinogenesis models.  Cancer Research. 4428-4428. 2017
• Abstract 3250: Computational drug repositioning and biochemical validation of piperlongumine as a potent therapeutic agent for neuroendocrine prostate cancer.  Cancer Research. 3250-3250. 2017
• Abstract 3772: A multi-scale survey to assess the impact of inflammatory diseases of the abdominal cavity and prostate cancer severity.  Cancer Research. 3772-3772. 2017
• Abstract 4603: Protocol optimization combining activatable nanodelivery with immunotherapy in a murine breast cancer model.  Cancer Research. 4603-4603. 2017
• Abstract LB-222: A nanoscale optical reporter implant for miRNA biomarkers in vivo.  Cancer Research. lb-222-lb-222. 2017
• Dietary amphiphilic polyphenols modulate the biophysical properties of plasma membrane organization and membrane-dependent macropinocytosis.  Cancer Research. 255-255. 2017
• Identifying genetic modifiers of PTEN using the Collaborative Cross mouse panel.  Cancer Research. 1542-1542. 2017
• Plasma membrane lipid therapy: disruption of oncogenic Ras spatiotemporal organization by membrane-targeted dietary bioactives (MTDB).  Cancer Research. 179-179. 2017
• Progression of epidermal growth factor receptor (EGFR)-independent colorectal cancer.  Cancer Research. 3400-3400. 2017
• Abstract AP22: CHEMORESISTANCE, TUMOR INITIATION AND TUMOR REEMERGENCE TRENDS IN MALIGNANT ASCITESDERIVED OVARIAN CANCER STEM CELL SPHEROIDS.  CLINICAL CANCER RESEARCH. ap22-ap22. 2017
• Abstract DPOC-012: THERANOSTIC NANOPLATFORM FOR IMAGEGUIDED SURGERY AND INTRAOPERATIVE PHOTOTHERAPY FOR OVARIAN CANCER TREATMENT.  CLINICAL CANCER RESEARCH. dpoc-012-dpoc-012. 2017
• Progression of colorectal cancer through epidermal growth factor receptor (EGFR)-independent mechanisms.  Cancer Research. a15-a15. 2017
• Abstract 4448: Elevated levels of circulating miR-34a-5p and miR-181c-3p during cancer initiation by aflatoxin B1.  Cancer Research. 4448-4448. 2017
• Genetic dissection of mechanisms underlying epidermal growth factor receptor-independent colorectal cancer development.  Cancer Research. lb-039-lb-039. 2016
• Photoacoustic detection and imaging of single cancer cells with peptide conjugated gold nanoparticles.  Cancer Research. lb-191-lb-191. 2016
• Abstract 465: CD44 as a potential therapeutic target and prognosis marker for glioblastoma.  Cancer Research. 465-465. 2016
• Abstract LB-052: Activatable nanodelivery combined with CpG-ODN and anti-PD-1 achieves a complete response in directly-treated and contralateral tumors in a murine breast cancer model.  Cancer Research. lb-052-lb-052. 2016
• Behavioral and clinical correlates of hepatocellular carcinoma among residents of South Central Texas: A case-control study.  Cancer Epidemiology, Biomarkers and Prevention. b38-b38. 2016
• Predictors of intention to obtain colorectal cancer screening among African American men in a state fair setting.  Cancer Epidemiology, Biomarkers and Prevention. b82-b82. 2016
• TWIST1 silences FOXA1 transcription to promote breast cancer progression.  Cancer Research. p2-05-23-p2-05-23. 2016
• Abstract P5-11-03: Development of an interactive text messaging tool to improve adherence with adjuvant endocrine therapy: Breast cancer endocrine therapy adherence (BETA) pilot study.  Cancer Research. p5-11-03-p5-11-03. 2016
• Abstract 1083: Temporal trends in microRNAs during subchronic aflatoxin dosing and modulation by the chemopreventive oleane triterpenoid, CDDO-Im.  Cancer Research. 1083-1083. 2016
• Changes in fatty acid profile indicate a chemo-preventive response to navy bean extract in an inflammation-associated colorectal cancer mouse model.  Molecular Cancer Research. a54-a54. 2016
• NF-kappaB-dependent and - independent roles for NIK in regulating GBM cell invasion.  Cancer Research. b36-b36. 2015
• Abstract 3879: Patient preferences for disclosure of incidental genetic information discovered through high-throughput sequencing.  Cancer Research. 3879-3879. 2015
• An optimized therapeutic nanoparticle delivery platform of miRNA in preclinical murine models of malignancy.  Cancer Research. 4291-4291. 2015
• Antitumor studies: Design, synthesis, antitumor activity and molecular docking study of novel 2-deoxo-2-substituted-5-deazaalloxazines.  Cancer Research. lb-098-lb-098. 2015
• PTHrP(12-48) localization is intracellular and it inhibits cell proliferation and osteoclastogenesis.  Cancer Research. 1041-1041. 2015
• The influence of masculinity, racism, and social support on colorectal cancer screening uptake among African American men: A systematic review.  Cancer Research. 3742-3742. 2015
• Abstract P3-11-02: Predictors of complete pathological response to neoadjuvant chemotherapy for breast cancer: 19,310 cases from the national cancer database treated in 2010 and 2011.  Cancer Research. p3-11-02-p3-11-02. 2015
• Abstract 695: Synergistic antitumor effects of polo like kinase inhibitor volasertib in combination with ionizing radiation in glioblastoma.  Cancer Research. 695-695. 2015
• Abstract PL03-01: A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner.  Cancer Prevention Research. pl03-01-pl03-01. 2015
• Mechanistic dissection of Ral GTPase signaling in driving KRAS-dependent pancreatic cancer growth.  Molecular Cancer Research. a08-a08. 2014
• Abstract 1536: Whole genome sequencing of high-grade treatment-nave prostate tumors.  Cancer Research. 1536-1536. 2014
• Diagnostic yield of clinical tumor and germline exome sequencing for newly diagnosed children with solid tumors.  Cancer Research. 5169-5169. 2014
• Dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner.  Cancer Research. sy04-02-sy04-02. 2014
• Early life exposure to air pollution and promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study.  Cancer Research. 265-265. 2014
• High content clonogenic survival assay for drug library screening identifies potent radiation sensitizers for non-small cell lung cancer.  Cancer Research. 4898-4898. 2014
• High-throughput in vitro screening of glioma stem cell lines: Evaluation of over 350 tyrosine kinase inhibitors.  Cancer Research. 3744-3744. 2014
• The microRNA profile is altered in fibrosis-associated hepatocarcinogenesis in mice.  Cancer Research. 5227-5227. 2014
• ERBB3 independent activation of the PI3K pathway in EGFR mutant lung adenocarcinomas..  MOLECULAR CANCER THERAPEUTICS. c113-c113. 2013
• High-throughput synthetic lethal drug screen to identify novel radiation sensitizers for KRAS mutant non-small cell lung cancer.  MOLECULAR CANCER THERAPEUTICS. b08-b08. 2013
• CEBPD (C/EBP) acts as a tumor suppressor in hormone receptor positive breast cancer cells and may serve as biomarker to predict the need for adjuvant therapy.  Cancer Research. 3464-3464. 2013
• Pharmacokinetic and pharmacodynamic evaluation of novel dual channel spray dried enteric coated self-emulsifying capsules for anti-cancer agents in dogs..  Cancer Research. 3361-3361. 2013
• Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry..  Cancer Research. 1352-1352. 2013
• Abstract 3644: Variation in transmembrane transport genes influence epithelial ovarian cancer risk and histopathologic subtype..  Cancer Research. 3644-3644. 2013
• Abstract 4850: Variation in circadian rhythm genes influence epithelial ovarian cancer risk and invasiveness..  Cancer Research. 4850-4850. 2013
• Abstract A39: Multimodal imaging of blood-brain barrier disruption during brain metastatic progression in a relevant experimental mouse model.  Cancer Research. a39-a39. 2013
• Gallotannins and Gallic acid From Mango Fruit (Mangifera Indica L) Suppress Breast Cancer Tumor Growth by Targeting Phosphatidylinositol3-kinase (PI3K)-Akt-NF-kB Pathway and Associated microRNAs.  Cancer Research. p5-07-03-p5-07-03. 2012
• Abstract B101: Inactivation of the orphan nuclear receptor TR3 induces ER stress-mediated apoptosis by increasing ROS production in pancreatic cancer cells..  b101-b101. 2012
• Analysis of genome-wide DNA methylation in CCRF-CEM cells confirms hypermethylation at reported epigenetic markers of T-cell lymphoblastic leukemia and identifies novel therapeutic targets with reduced methylation upon treatment with dietary indoles.  Cancer Research. 5430-5430. 2012
• Differential effects of sulforaphane and related isothiocyanates on HDAC turnover and the DNA damage response in colon cancer cells.  Cancer Research. lb-184-lb-184. 2012
• SRC-3 is a critical mediator in the development of castration-resistant prostate cancer.  Cancer Research. 3296-3296. 2012
• Senescence reversion contributes to acquired drug resistance.  Cancer Research. 4230-4230. 2012
• Abstract 3592: Risk factors of prostate cancer in African American men.  Cancer Research. 3592-3592. 2012
• Activation of Putative Compensatory Pathways upon Deletion of Erbb3 in Mutant EGFR-driven Lung Cancer.  CLINICAL CANCER RESEARCH. b35-b35. 2012
• Proteomic Analysis of Patient Plasma Identifies Parathyroid Hormone Related Protein (PTHrP12-48) as a Potential Biomarker of Breast Cancer Bone Metastasis..  Cancer Research. p4-16-01-p4-16-01. 2011
• Defining two populations of prostate cancer cells with distinct molecular, biological, and tumor-propagating properties.  Cancer Research. 476-476. 2011
• Drug resistance and invasion in diffuse large B-cell lymphoma are mediated by Akt, 14-3-3 zeta, and Vimentin.  Cancer Research. 702-702. 2011
• Travel distance and pattern of care for laryngeal cancer in Kentucky.  Cancer Research. 1928-1928. 2011
• Whole methylome explorations of paired tumor and non-tumor clinical samples using HELP.  Cancer Research. 4820-4820. 2011
• Docosahexaenoic acid alters the spatio-temporal segregation and activation of EGF receptor.  Cancer Research. 276-276. 2010
• Quantitative trait locus analysis of tumor morphology in a mouse model of human colorectal cancer.  Cancer Research. 2126-2126. 2010
• n-3 polyunsaturated fatty acids promote apoptosis in oxidatively stressed transgenic mouse models.  Cancer Research. 955-955. 2010
• Abstract 18: Targeted epidermal ablation of EGFR causes local and systemic inflammation.  Cancer Research. 18-18. 2010
• Abstract 5538: Enhanced tumor cytotoxicity of a combinational therapy using liposomal copper-doxorubicin, rapamycin, and ultrasound.  Cancer Research. 5538-5538. 2010
• Exosomal microRNAs are associated with prostate cancer aggressiveness in African American patients.  Cancer Epidemiology, Biomarkers and Prevention. b045-b045.
• Gsta4 modifies susceptibility to skin tumor development in mice and humans.  Cancer Research. 4210-4210.